Flecainide is a class 1C antiarrhythmic drug especially used for the management ofsupraventricular arrhythmia. In overdose cases, flecainide can induce life treating ventriculararrhythmias and cardiogenic shock. We report the case of a 72-year-old woman admitted toour intensive care unit for a regular monomorphic wide complex tachycardia (QRS duration240 ms, right bundle branch block and superior axis morphology) without apparent P waves.Clinical examination showed slight left congestive heart failure signs without cardiogenicshock. An intravenous bolus of 10 mg adenosine 5’-triphosphate (ATP) was ineffective to stopthe tachycardia. The diagnosis of ventricular tachycardia induced by flecainide overdose wasconsidered. 500 mL of intravenous ...
Antiarrhythmic agents may increase capture threshold, but this is rarely of clinical significance. F...
A 67-year-old woman was initially complaining of breath-lessness and had a single syncope before she...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...
Flecainide acetate is a class 1C antiarrhythmic most often used for supraventricular arrhythmias. In...
Flecainide is a Vaughn-Williams class IC antiarrhythmic used in the treatment of supraventricular ta...
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with ...
BACKGROUND Flecainide is a class Ic antiarrhythmic agent used in the treatment of supraventricular a...
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk med...
Background: Flecainide is a potent class 1C antidysrhythmic that interferes with sodium channel card...
AbstractFlecainide (a class 1c antiarrhythmic) produces a dose-dependent decrease in intracardiac co...
Flecainide acetate is a Vaughan Williams class 1C anti-arrhythmic agent. Overdose causes severe card...
Flecainide has demonstrated unsurpassed antiarrhythmic activity in patients with stable ventricular ...
Thirty-eight patients with organic heart disease and history of sudden cardiac arrest or recurrent s...
Effective antiarrhythmic therapy requires a carefully considered approach, including an understandin...
BACKGROUND: Drugs not commonly considered to be cardioactive agents may cause prolongation of the Q...
Antiarrhythmic agents may increase capture threshold, but this is rarely of clinical significance. F...
A 67-year-old woman was initially complaining of breath-lessness and had a single syncope before she...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...
Flecainide acetate is a class 1C antiarrhythmic most often used for supraventricular arrhythmias. In...
Flecainide is a Vaughn-Williams class IC antiarrhythmic used in the treatment of supraventricular ta...
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with ...
BACKGROUND Flecainide is a class Ic antiarrhythmic agent used in the treatment of supraventricular a...
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk med...
Background: Flecainide is a potent class 1C antidysrhythmic that interferes with sodium channel card...
AbstractFlecainide (a class 1c antiarrhythmic) produces a dose-dependent decrease in intracardiac co...
Flecainide acetate is a Vaughan Williams class 1C anti-arrhythmic agent. Overdose causes severe card...
Flecainide has demonstrated unsurpassed antiarrhythmic activity in patients with stable ventricular ...
Thirty-eight patients with organic heart disease and history of sudden cardiac arrest or recurrent s...
Effective antiarrhythmic therapy requires a carefully considered approach, including an understandin...
BACKGROUND: Drugs not commonly considered to be cardioactive agents may cause prolongation of the Q...
Antiarrhythmic agents may increase capture threshold, but this is rarely of clinical significance. F...
A 67-year-old woman was initially complaining of breath-lessness and had a single syncope before she...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...